Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients
ConditionHemolytic Anemia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSohag University
About this trial
the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases.
And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18 years and older.
Patients diagnosed with acquired hemolytic anemia.
Patients must be hospitalized in the Internal Medicine department at the time of diagnosis of acquired hemolytic anemia during the study period
Patients (or their legal representatives) must provide informed
Disqualifiers
Patients with underlying neoplastic diseases.
Patients with hereditary hemolytic anemia.
Patients or their representatives who do not consent to participate in the study.
Trial population
patients admitted in Internal Medicine department and Intermediate care unit at sohag university hospital
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
blood samples
Other interventionblood samples for CBC parameters , peripheral blood smear, bilirubin levels and kidney function tests
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
intensive care unit admission of the patients due to progression of the disease complications.
Primary outcome will be ICU admission due to progression of the disease complications.
Time frame
through study completion, an average of 6 monthsSecondary outcomes
1
mortality within duration of hospital admission
Secondary outcome will be mortality within duration of hospital admission
Time frame
through study completion, an average of 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: